Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

TLIS

Talis Biomedical (TLIS)

Talis Biomedical Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:TLIS
DateTimeSourceHeadlineSymbolCompany
05/08/20247:04AMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
01/26/20243:33PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
11/14/20237:00AMGlobeNewswire Inc.Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve CashNASDAQ:TLISTalis Biomedical Corporation
09/01/20234:00PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
08/10/20234:01PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:TLISTalis Biomedical Corporation
08/10/20233:46PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:TLISTalis Biomedical Corporation
08/10/20233:11PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
08/10/20233:05PMGlobeNewswire Inc.Talis Biomedical Announces Second Quarter 2023 Financial Results and Business UpdateNASDAQ:TLISTalis Biomedical Corporation
08/03/20237:00AMGlobeNewswire Inc.Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023NASDAQ:TLISTalis Biomedical Corporation
08/02/20237:18AMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
08/02/20237:17AMEdgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
08/02/20237:15AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
08/02/20237:00AMGlobeNewswire Inc.Talis Biomedical Announces Andrew Lukowiak, Ph.D., as President and Chief Scientific Officer (CSO)NASDAQ:TLISTalis Biomedical Corporation
07/27/20237:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
07/27/20237:00AMGlobeNewswire Inc.New Data Presented at the Infectious Disease Society for Obstetrics and Gynecology (IDSOG) Annual Meeting Differentiate Talis Biomedical’s Women’s and Sexual Health Product MenuNASDAQ:TLISTalis Biomedical Corporation
07/24/20237:41AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
07/24/20237:00AMGlobeNewswire Inc.Talis Biomedical Regains Compliance with Nasdaq Minimum Bid Price RequirementNASDAQ:TLISTalis Biomedical Corporation
07/18/20234:37PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TLISTalis Biomedical Corporation
07/05/20237:10AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:TLISTalis Biomedical Corporation
07/05/20237:00AMGlobeNewswire Inc.Talis Biomedical Announces 1-for-15 Reverse Stock SplitNASDAQ:TLISTalis Biomedical Corporation
06/13/20233:53PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
06/12/20234:28PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
06/12/20234:26PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
06/12/20234:24PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
06/12/20234:22PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
06/12/20234:14PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:TLISTalis Biomedical Corporation
06/09/20233:11PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
05/23/20237:16AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
05/23/20237:00AMGlobeNewswire Inc.Talis Biomedical Appoints Former Roche Molecular CEO Heiner Dreismann to Board of Directors, Announces Former Genomic Health CEO Kim Popovits as Lead Independent DirectorNASDAQ:TLISTalis Biomedical Corporation
05/11/20233:38PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:TLISTalis Biomedical Corporation
 Showing the most relevant articles for your search:NASDAQ:TLIS